Literature DB >> 10048983

Integrin alpha6beta1 role in metastatic behavior of human pancreatic carcinoma cells.

R Vogelmann1, E D Kreuser, G Adler, M P Lutz.   

Abstract

The factors that determine the metastatic behavior of pancreatic tumor cells are incompletely understood. In this study, we first demonstrate differences in adhesion properties, integrin expression and in vivo integrin function in the metastatic tumor cell line PaTu 8988s compared with the non-metastatic cell line PaTu 8988t. Both cell lines were derived from the same original tumor and exhibit identical genetic fingerprints. Using in vitro adhesion assays performed on purified extracellular matrix components, adhesion of PaTu 8988s cells was significantly increased on the basal membrane component laminin and decreased on the interstitial matrix protein fibronectin compared to PaTu 8988t cells. By immunocytochemistry and flow cytometry, and in correspondence with their adhesive properties, the metastatic PaTu 8988s cells did express a distinct pattern of integrin subunits. Laminin-binding integrins alpha6 and beta4 were overexpressed in PaTu 8988s cells. Fibronectin-binding alpha5 integrins were present at higher levels in the non-metastatic PaTu 8988t cells, whereas the beta1 subunit expression did not differ. Adhesion to laminin or fibronectin was specific and was mediated via integrins alpha6beta1 and alpha5beta1, respectively. In addition, metastasis formation in vivo after injection of cells into the tail vein of nude mice was inhibited by preincubation of PaTu 8988s cells with antibodies directed against the integrin alpha6 or beta1. We conclude that alpha6beta1 integrins are overexpressed and functionally active in metastatic human pancreatic carcinoma cells, and participate in metastasis formation probably through binding to the basal membrane component laminin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048983     DOI: 10.1002/(sici)1097-0215(19990301)80:5<791::aid-ijc25>3.0.co;2-4

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  Knockdown of the β(1) integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis.

Authors:  John J Grzesiak; Hop S Tran Cao; Douglas W Burton; Sharmeela Kaushal; Fabian Vargas; Paul Clopton; Cynthia S Snyder; Leonard J Deftos; Robert M Hoffman; Michael Bouvet
Journal:  Int J Cancer       Date:  2011-04-13       Impact factor: 7.396

2.  αv integrin: a new gastrin target in human pancreatic cancer cells.

Authors:  Celine Cayrol; Claudine Bertrand; Aline Kowalski-Chauvel; Laurence Daulhac; Elizabeth Cohen-Jonathan-Moyal; Audrey Ferrand; Catherine Seva
Journal:  World J Gastroenterol       Date:  2011-10-28       Impact factor: 5.742

3.  Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites.

Authors:  Monika Schmelz; Anne E Cress; Katherine M Scott; Friederike Bürger; Haiyan Cui; Karim Sallam; Kathy M McDaniel; Bruce L Dalkin; Raymond B Nagle
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

4.  A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.

Authors:  S R Elshaw; K Sisley; N Cross; A K Murray; S M MacNeil; M Wagner; C E Nichols; I G Rennie
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

5.  Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers.

Authors:  William L Harryman; Erika Pond; Parminder Singh; Andrew S Little; Jennifer M Eschbacher; Raymond B Nagle; Anne E Cress
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

6.  Butyrate inhibits pancreatic cancer invasion.

Authors:  Buckminster Farrow; Piotr Rychahou; Kathleen L O'Connor; B Mark Evers
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

7.  Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma.

Authors:  David F Schaeffer; Kiran Assi; Katie Chan; Andrzej K Buczkowski; Stephen W Chung; Charles H Scudamore; Alan Weiss; Bill Salh; David A Owen
Journal:  Virchows Arch       Date:  2010-01-21       Impact factor: 4.064

8.  Expression and prognostic roles of integrins and interleukin-1 receptor type I in patients with ductal adenocarcinoma of the pancreas.

Authors:  Hirozumi Sawai; Hitoshi Funahashi; Yoichi Matsuo; Minoru Yamamoto; Yuji Okada; Tetsushi Hayakawa; Tadao Manabe
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

9.  Alterations in integrin expression modulates invasion of pancreatic cancer cells.

Authors:  Naomi Walsh; Martin Clynes; John Crown; Norma O'Donovan
Journal:  J Exp Clin Cancer Res       Date:  2009-10-13

Review 10.  Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets.

Authors:  Christopher S Stipp
Journal:  Expert Rev Mol Med       Date:  2010-01-18       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.